These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Progress report on immunotherapy of chronic myeloid leukemia. Sokal JE; Carpenter N; Nizet C Boll Ist Sieroter Milan; 1978 Jul; 57(3):294-305. PubMed ID: 282900 [TBL] [Abstract][Full Text] [Related]
8. Phase II trial of active immunotherapy of acute myeloid leukemia. Mathé G; Musset M; Schwarzenberg L; Hayat M; de Vassal F; Amiel JL; Pouillart P; Misset JL Biomedicine; 1975 Sep; 23(7):291-3. PubMed ID: 1066168 [TBL] [Abstract][Full Text] [Related]
9. The role of immunotherapy in acute myelogenous leukemia. Foon KA; Smalley RV; Riggs CW; Gale RP Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818 [TBL] [Abstract][Full Text] [Related]
10. [BCG, or immunotherapy of hope]. Monti A Minerva Med; 1975 Oct; 66(68 Suppl):7-9. PubMed ID: 1059000 [No Abstract] [Full Text] [Related]
11. [Attempt at immunotherapy using BCG vaccine in acute leukemia]. Kardaszewicz E Acta Haematol Pol; 1972; 3(3):251-6. PubMed ID: 4649308 [No Abstract] [Full Text] [Related]
12. Immunotherapy in the management of myelogenous leukemia. Fairley GH Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553 [TBL] [Abstract][Full Text] [Related]
13. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity. Arends-Merino A; Sjögren AM; Reizenstein P Anticancer Res; 1983; 3(4):239-41. PubMed ID: 6576728 [TBL] [Abstract][Full Text] [Related]
14. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse. Powles R; Toy JL Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466 [TBL] [Abstract][Full Text] [Related]
15. Results of treatment of acute leukaemias with BCG vaccine. Kardaszewicz E; Japa J J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):20-4. PubMed ID: 1063220 [No Abstract] [Full Text] [Related]
16. [BCG immunotherapy in chronic myeloid leukemia]. Kardaszewicz E; Siejeńska L Pol Arch Med Wewn; 1975 Jul; 54(1):7-13. PubMed ID: 1057161 [No Abstract] [Full Text] [Related]
17. [Role of immunotherapy in the treatment of leukemias]. Alexander P Recenti Prog Med; 1975 Oct; 59(4):301-13. PubMed ID: 769101 [No Abstract] [Full Text] [Related]
18. Immunotherapy of chronic myelocytic leukemia: effects of different vaccination schedules. Sokal JE; Aungst CW; Snyderman M; Gomez G Ann N Y Acad Sci; 1976; 277(00):367-83. PubMed ID: 1069556 [TBL] [Abstract][Full Text] [Related]
19. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy. Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232 [TBL] [Abstract][Full Text] [Related]